IP Library Patent Application 11844536
Patent Application
App. No. 11/844,536

WOUND DRESSING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/844,536
Filed
Aug 24, 2007
Art Unit
1611
USPC
424/445
Abstract

The invention provides for the use of an effective amount of silver in the manufacture of a wound dressing comprising an anionic polymer, which dressing, when applied to the wound, gives a controlled release of ionic silver into the wound fluid for the prevention of staining of the underlying tissue.

Claims (9)

1 . A wound dressing comprising an anionic, amphoteric or hydrophilic polymer, and an effective amount of silver, which dressing, when placed in water gives a release of ionic silver into water of less than 1.5 ppm, and when in contact with wound exudate, gives a controlled release of ionic silver into the wound exudate.

2 . The wound dressing of claim 1 , wherein the anionic, amphoteric or hydrophilic polymer is selected from the group consisting of polysaccharides, modified polysaccharides, polyvinylpyrrolidone, polyvinyl alcohols, polyvinyl ethers, polyurethanes, polyacrylates, polyacrylamides, collagen, gelatin and mixtures thereof.

3 . The wound dressing of claim 1 , wherein the wound dressing is in the form of fibers, or a powder, or distributed within a matrix of an adhesive.

4 . The wound dressing of claim 1 , wherein the wound dressing comprises from 0.1 to 20% by weight of silver.

5 . A method for the prevention of skin staining of a wound treated with a silver containing wound dressing comprising applying to a wound a wound dressing which, when placed in water, gives a release of ionic silver into water of less than 1.5 ppm, and when in contact with wound exudate, gives a controlled release of ionic silver into the wound exudate.

6 . The method of claim 5 wherein the wound dressing comprises an anionic, amphoteric or hydrophilic polymer.

7 . The method of claim 6 wherein the anionic, amphoteric or hydrophilic polymer is selected from the group consisting of polysaccharides, modified polysaccharides, polyvinylpyrrolidone, polyvinyl alcohols, polyvinyl ethers, polyurethanes, polyacrylates, polyacrylamides, collagen, gelatin and mixtures thereof.

8 . The method of claim 6 wherein the wound dressing is in the form of fibers, or a powder, or distributed within a matrix of an adhesive.

9 . The method of claim 5 wherein the wound dressing comprises from 0.1 to 20% by weight of silver.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Nov 2, 2016
From: JPMORGAN CHASE BANK, N.A.
To: CONVATEC TECHNOLOGIES, INC.; CONVATEC LIMITED; UNOMEDICAL LIMITED; UNOMEDICAL A/S
Reel/Frame 040543/0357 →
SECURITY AGREEMENT Recorded Jan 6, 2011
From: CONVATEC TECHNOLOGIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 025591/0856 →
RELEASE OF SECURITY INTEREST AT 021901/0419 Recorded Jan 4, 2011
From: J.P. MORGAN EUROPE LIMITED
To: CONVATEC TECHNOLOGIES, INC.
Reel/Frame 025580/0879 →
SECURITY AGREEMENT Recorded Dec 1, 2008
From: CONVATEC TECHNOLOGIES INC.
To: J.P. MORGAN EUROPE LIMITED
Reel/Frame 021901/0419 →
RELEASE OF SECURITY INTEREST Recorded Nov 28, 2008
From: J.P. MORGAN EUROPE LIMITED
To: CONVATEC INC.
Reel/Frame 021890/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2008
From: BRISTOL-MYERS SQUIBB COMPANY; CONVATEC, INC.
To: CONVATEC TECHNOLOGIES INC.
Reel/Frame 021754/0611 →
SECURITY AGREEMENT Recorded Aug 12, 2008
From: CONVATEC INC.
To: J.P. MORGAN EUROPE LIMITED
Reel/Frame 021371/0796 →